Composite eye-moistening liquid and its application
A composition and eye-moisturizing technology, applied in the direction of drug combination, medical preparations containing active ingredients, organic active ingredients, etc., can solve unsatisfactory problems, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0022] The preparation of embodiment 1 composition solution of the present invention
[0023] Prepare according to the following proportions:
[0024] Sodium hyaluronate (MW=1.2×10 6 ) 0.5wt%
[0025] PVP (MW=3×10 4 ) 1.0wt%
[0026] Sodium Phosphate 0.8wt%
[0027] EDTA-2Na 0.1wt%
[0028] Polyhexamethylene biguanide 0.00015wt%
[0029] Sodium chloride 0.41wt%
[0030] Water added to 100wt%
[0031] Adjust the pH with appropriate amount of hydrochloric acid or sodium hydroxide
[0032] First heat 20wt% water to 40°C, gradually add HA, PVP and EDTA-2Na under stirring, after dissolving, cool to room temperature and then add polyhexamethylene biguanide, NaCl and sodium phosphate, add to 100wt% with pure water . Adjust the pH with HCl or NaOH, measure the osmotic pressure and pH value of the solution, the osmotic pressure is 292mOsm / KgH 2 O, the pH value is 7.23. The solution is then packaged for storage.
Embodiment 2
[0033] Example 2 Testing the comfort and safety of compositions with different molecular weights and different amounts of sodium hyaluronate
[0034] Solution A
Solution B
Solution C
Solution D
Sodium hyaluronate
(MW is 1.2 million)
0.5wt%
0.0001wt%
Sodium hyaluronate
(MW is 500,000)
0.5wt%
0.0001wt%
polyvinylpyrrolidone
(MW is 30,000)
1.2wt%
1.2wt%
1.2wt%
1.2wt%
sodium borate
0.8wt%
0.8wt%
0.8wt%
0.8wt%
EDTA-2Na
0.1wt%
0.1wt%
0.1wt%
0.1wt%
Sodium chloride
0.41wt%
0.41wt%
0.41wt%
0.41wt%
polyhexamethylene biguanide
0.00012wt%
0.00012wt%
0.00012wt%
0.00012wt%
water
Add to 100wt%
Add to 100wt%
Add to 100wt%
Add to 100wt%
[0035] The molecular weight (MW) of sodium hyaluronate (eye drop grade) currently available on the market is ...
Embodiment 3
[0041] Example 3 Testing the comfort and safety of compositions with different molecular weights and different amounts of polyvinylpyrrolidone
[0042] Solution E
[0043] Among them, PVP-K30 is a linear homopolymer with a molecular weight of about 30,000, provided by BASF, and cl-PVP3040 is a cross-linked homopolymer with an average molecular weight of 3×10 5 , provided by BASF Corporation. The above-mentioned four E-H solutions were prepared according to the steps of Example 1 with the proportioning described in Table 3, and the intrinsic viscosity was measured with an Ubbelohde viscometer. The viscosities of the four solutions were H>G>F>E.
[0044] The eye drops experiment was carried out according to the steps of Example 2, and the comparison groups were E to F, G to H, F to G, and E to G. The specific results are shown in Table 4:
[0045] group
[0046] It can be seen from the above results that the effect of cross-linked PVP3040 is much more sig...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap